EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Psoriatic arthritis and psoriasis severity as metabolic syndrome and insulin resistance predictors

Olivera Levakov, Zorica Gajinov, Branislava Gajic, Ljuba Vujanovic, Milana Ivkov-Simic, Zoran Golusin

Srpski arhiv za celokupno lekarstvo · 2022 · 150 (7-8) · 456-461

DOI: 10.2298/sarh220311056l ↗

Kurz gefasst

Fachartikel in der Zeitschrift Srpski arhiv za celokupno lekarstvo, 2022. Verfasst von Olivera Levakov und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Objective. The aim of this study was to evaluate psoriasis severity and psoriatic arthritis (PsA) as metabolic syndrome (MetS) and insulin resistance (IR) predictors in patients with chronic plaque psoriasis as well as to evaluate if psoriasis severity and PsA are independent predictors for IR regardless of the MetS presence.

Methods

This prospective, observational descriptive cross-sectional study was conducted at Dermatovenereological Clinic of the University Clinical Centre of Vojvodina, and included a total of 105 psoriasis patients divided into three groups: group with mild psoriasis (Psoriasis Area Severity Index ? PASI score < 10), group with moderate to severe psoriasis (PASI ?10), and group with PsA diagnosed on the basis of the CASPAR criteria.

Results

Percentage of patients who had MetS was higher in the group with the severe form of psoriasis (p < 0.05) as well as IR (p = 0.05). PsA was also more frequently associated with MetS (p = 0.05) and IR (p < 0.01). In patients without MetS, no association between psoriasis severity and IR was found (p = 1.0), although there was a positive correlation between PASI and index of ?-cells secretory capacity % (HOMA B), which shows tendency for IR development. The association between PsA and presence of IR in patients without MetS was statistically significant (p < 0.05).

Conclusion

MetS and IR prevalence increases in patients with PsA and in patients with the moderate and severe form of chronic plaque psoriasis. Both psoriasis severity and PsA are independent predictors for IR regardless of the MetS presence.

Zitieren

APA

Levakov, O., Gajinov, Z., Gajic, B., Vujanovic, L., Ivkov-Simic, M., & Golusin, Z. (2022). Psoriatic arthritis and psoriasis severity as metabolic syndrome and insulin resistance predictors. Srpski arhiv za celokupno lekarstvo, 150(7-8), 456-461. https://doi.org/10.2298/sarh220311056l

Vancouver

Levakov O, Gajinov Z, Gajic B, Vujanovic L, Ivkov-Simic M, Golusin Z. Psoriatic arthritis and psoriasis severity as metabolic syndrome and insulin resistance predictors. Srpski arhiv za celokupno lekarstvo. 2022;150(7-8):456-461. doi:10.2298/sarh220311056l

BibTeX
@article{Levakov2022,
  author = {Levakov, Olivera and Gajinov, Zorica and Gajic, Branislava and Vujanovic, Ljuba and Ivkov-Simic, Milana and Golusin, Zoran},
  title = {Psoriatic arthritis and psoriasis severity as metabolic syndrome and insulin resistance predictors},
  journal = {Srpski arhiv za celokupno lekarstvo},
  year = {2022},
  volume = {150},
  number = {7-8},
  pages = {456--461},
  doi = {10.2298/sarh220311056l}
}
Kostenlos starten →